Sharon M. Watling
2012
In 2012, Sharon M. Watling earned a total compensation of $454.5K as Former Vice President Clinical Development at Vericel, a 27% decrease compared to previous year.
Compensation breakdown
| Option Awards | $199,062 |
|---|---|
| Salary | $245,000 |
| Other | $10,429 |
| Total | $454,491 |
Watling received $245K in salary, accounting for 54% of the total pay in 2012.
Watling also received $199.1K in option awards and $10.4K in other compensation.
Rankings
In 2012, Sharon M. Watling's compensation ranked 9,042nd out of 11,487 executives tracked by ExecPay. In other words, Watling earned more than 21.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,042 out of 11,487 | 21st |
Division Manufacturing | 3,314 out of 4,253 | 22nd |
Major group Chemicals And Allied Products | 892 out of 1,198 | 26th |
Industry group Drugs | 659 out of 920 | 28th |
Industry Biological Products, Except Diagnostic Substances | 116 out of 160 | 28th |
Source: SEC filing on October 21, 2014.
Watling's colleagues
We found four more compensation records of executives who worked with Sharon M. Watling at Vericel in 2012.